Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

AMSTERDAM, February 20 /PRNewswire/ --

- Conference Call & Webcast Today at 10:00 CET

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today reported its full year 2007 results.

Highlights

- Successful IPO, raising gross proceeds of EUR 55.7 million

- Cash & cash equivalents of EUR 51.3 million at June 30, 2007

- U.S. FDA orphan drug designation for lead product AMT 011

- Positive results of Phase I/II in LPL type I deficiency

- Pre-registration trial in Canada on track

- Appointment of Ferdinand Verdonck as chairman of supervisory board.

- Global rights for acute intermittent porphyria treatment

- Exclusive license to all gene therapy products from CIMA

PHILADELPHIA and LONDON, February 20 /PRNewswire/ --

- Survey Takes a Look at Who Had the Highest Impact in Molecular Biology and Genetics 2002-2006

Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and business communities, today announced the results of a study assessing high-impact research in molecular biology and genetics. In the January/February issue of Science Watch, Thomson Scientific analyzes data from its Essential Science Indicators to identify molecular biology and genetics papers that rank among the top one percent most cited in the field for their respective years of publication between 2002 and 2006.

BOSTON, February 19 /PRNewswire/ --

- B2BGateway's New Client Portal Allows NetSuite Users to Easily Manage and Connect to Any Electronic Data Interchange (EDI) Trading Partners

LONDON, February 19 /PRNewswire/ --

Northrop Grumman Corporation (NYSE: NOC) continues to grow its international business in remote control vehicles for explosive ordnance disposal (EOD) with recent sales of its Revolution vehicles across the Asia and Asia Pacific regions.

A photo accompanying this release is available at: http://media.primezone.com/noc/

TRAPPES, France, February 19 /PRNewswire/ -- Nissan Motor Co., Ltd., is taking another opportunity to showcase its latest environmental innovations by becoming an official partner of EVER Monaco 2008, an automotive show devoted to Ecological Vehicles and Renewable Energies.

The Expo, which is held in the Principality from 27-30 March, is dedicated to all forms of transport powered by fuels offering a real ecological benefit. The spotlight will fall on vehicles powered by electricity, fuel cell, gas and bio fuels as well as on hybrids.

BRACKNELL, England, February 19 /PRNewswire/ -- Monday's BBC Panorama programme highlighted the environmental cost of drinking bottled water and interviewed environment minister Phil Woolas who urged UK consumers and businesses to rethink their choices. The programme also featured a meeting at the Department for Environment, Food and Rural Affairs (DEFRA) where tap water was served in a jug.